A systematic review and meta‐analysis of the impacts of germline pharmacogenomics on severe toxicity and symptom burden in adult patients with cancer
S Lingaratnam, M Shah, J Nicolazzo… - Clinical and …, 2024 - Wiley Online Library
The clinical application of Pharmacogenomics (PGx) has improved patient safety. However,
comprehensive PGx testing has not been widely adopted in clinical practice, and significant …
comprehensive PGx testing has not been widely adopted in clinical practice, and significant …
Mapping the Pharmacogenetic Landscape in a Ugandan Population: Implications for Personalized Medicine in an Underrepresented Population
Africans are extremely underrepresented in global genomic research. African populations
face high burdens of communicable and non‐communicable diseases and experience …
face high burdens of communicable and non‐communicable diseases and experience …
CYP2D6 and CYP2C19 Variant Coverage of Commercial Antidepressant Pharmacogenomic Testing Panels Available in Victoria, Australia
M Forbes, M Hopwood, CA Bousman - Genes, 2023 - mdpi.com
Pharmacogenomic (PGx) testing to inform antidepressant medication selection and dosing
is gaining attention from healthcare professionals, patients, and payors in Australia …
is gaining attention from healthcare professionals, patients, and payors in Australia …
Commentary: The pharmacogenomic landscape of an Indigenous Australian population
We write to commend Samarasinghe and colleagues on their collaborative and progressive
research in Indigenous Australian health and to acknowledge the important clinical …
research in Indigenous Australian health and to acknowledge the important clinical …